Communicate with Supplier? Supplier
Lily Ms. Lily
What can I do for you?
Contact Supplier

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

Products

Home > Products > APIs And Intermediates > Acalabrutinib

Acalabrutinib

Product categories of Acalabrutinib, we are specialized manufacturers from China, Calquence, Acalabrutinib Cll suppliers/factory, wholesale high-quality products of Calquence Cll R & D and manufacturing, we have the perfect after-sales service and technical support. Look forward to your cooperation!

View:

    • CAS NO.1420477-60-6 Acalabrutinib 99.0%+

    CAS NO.1420477-60-6 Acalabrutinib 99.0%+

    • Packaging: Double PE Bag with Foil Bag or as required

    • Supply Ability: As per order

    • Min. Order: 0.01 Kilogram

    • Certificate: ISO9001

    • Model No.: DM 1420477-60-6

    Golden Product Acalabrutinib CAS NO 1420477 60 6 with Best Price Product Name Acalabrutinib CAS NO 1420477 60

    • Acalabrutinib Intermediate/4-(pyridin-2-yl-aminocarbonyl)benzeneboronic acid CAS 850568-25-1

    Acalabrutinib Intermediate/4-(pyridin-2-yl-aminocarbonyl)benzeneboronic acid CAS 850568-25-1

    • Brand: DM

    • Packaging: double PE with aluminium foil bag

    • Min. Order: 1 Gram

    • Certificate: ISO9001

    • Model No.: CAS 850568-25-1

    Acalabrutinib Intermediate 4 pyridin 2 yl aminocarbonyl benzeneboronic acid CAS 850568 25 1 CAS 850568 25 1 MF C12H11BN2O3 MW 242 04 Synonyms 4 PYRIDIN 2 YL AMINOCARBONYL BENZENEBORONIC ACID 4 PYRIDIN 2 YL AMINOCARBONYLPHENYLBORONIC ACID N 2 PYRIDINYL 4 BORONOBENZAMIDE 4 Pyridin 2 yl aminocarbonyl benzeneboronic acid...

    • Acalabrutinib CAS:1420477-60-6

    Acalabrutinib CAS:1420477-60-6

    • Brand: DM

    • Packaging: double PE with aluminium foil bag

    • Min. Order: 1 Gram

    • Certificate: ISO9001

    • Model No.: CAS:1420477-60-6

    Name Acalabrutinib ACP196 CAS 1420477 60 6 Appearance White crystalline powder Application API Acalabrutinib also known as ACP 196 is an orally available inhibitor of Bruton s tyrosine kinase BTK with potential antineoplastic activity Upon administration ACP 196 inhibits the activity of BTK and prevents the activation...

China Acalabrutinib Suppliers

Acalabrutinib, also known as ACP-196, is an orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, ACP-196 inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.

Send Inquiry

Tel:86-311-67260775

Fax:86-311-67591193

Mobile Phone:+8615933619867

Email:sales@dingminpharma.com

Address:No.52 Zhaiying South Street,Yuhua District, Shijiazhuang, Hebei

Mobile Site